Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11904108 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism
Conditions: Iron Deficiency Anemia;   Subclinical Hypothyroidism
Interventions: Drug: Ferrous sulfate tablets 325 mg, po, TID;   Drug: Ferrous sulfate plus levothyroxine

Indicates status has not been verified in more than two years